The legal distinction in the United States between a cosmetic and a drug

REFERENCES

• Corson, R. Fashions in Makeup from Ancient to Modern Times 8, 1972.
   Google Scholar
• Pliny. Natural History, H. Rackham, W.H.S. Jones, 1938–1962; Vols. I–X
   Google Scholar
• Mass, L. c. 171, April 29, 1886.
   Google Scholar
• Hutt P.B., Hutt P.B., II. A History of Government Regulation of Adulteration and Misbranding of Food. Food Drug Cosmet. Law J. 1984; 39: 247–53
   Google Scholar
• H.R. 9154, 55th Cong., 2d Sess., 1898; S. 4144, 55th Cong., 2d Sess., 1898.
   Google Scholar
• Anderson O.E. Pioneer Statute: The Pure Food and Drugs Act of 1906. J. Publ. Law 1964; 13: 189–195
   Google Scholar
• 34 Stat. 768, 1906.
   Google Scholar
• 52 Stat. 1040, 21 U.S.C. 301 et seq., 1938.
   Google Scholar
• Hutt P.B. A Historical Introduction. Food Drug Cosmet. Law J. 1990; 45: 17
   Google Scholar
• 1917 Report of Bureau of Chemistry 15–16, in Food Law Institute, Federal Food, Drug, and Cosmetic Law Administrative Reports: 1907–1949, 355, 369–370, 1951.
   Google Scholar
• S. 1944, 73d Cong., 1st Sess., 1933.
   Google Scholar
• 1933 Report of Food & Drug Administration 13, in Food Law Institute, note 11 supra, at 787–799.
   Google Scholar
• Note 9 supra.
   Google Scholar
• Section 6, 34 Stat., 768, 769, 1906.
   Google Scholar
• S. Rep. No. 361, 74th Cong., 1st. Sess. 4, 1935.
   Google Scholar
• The legislative history of this prong of the drug definition is reviewed exhaustively in American Health Products Co., Inc. v. Hayes, 574 F. Supp. 1498 (S.D.N.Y. 1983), affirmed on other grounds, American Health Products Co. v. Hayes. 744 F.2d 912 (2d Cir. 1984) (per curiam).
   Google Scholar
• S. Rep. No. 361, 74th Cong., 1st Sess. 4, 1935.
   Google Scholar
• 79 Cong. Rec. 4845, April 2, 1935.
   Google Scholar
• United States v. An Article of Drug. . . Ova II, 414 F. Supp. 660 (D.N.J. 1975), affirmed without opinion. 535 F.2d 12448, 1975.
   Google Scholar
• See generally Hutt, P.B.; Merrill, R.A. Food and Drug Law Cases and Materials Chapter III, 1991.
   Google Scholar
• Calvery, H.O. Safeguarding foods and drugs in wartime. 32 Am Sci, No. 2, at 103, 119, 1944.
   Google Scholar
• FDA. Facts for Consumers—Cosmetics, Pub. No. 26, at 6 (1965); FDA Trade Correspondence No. 245, April 25, 1940.
   Google Scholar
• Almay, Inc. v. Califano, 569 F.2d 674, D.C. Cir. 1977.
   Google Scholar
• Cf. United States v. Articles of Food and Drug. 444 F. Supp. 266, 271, E.D. Wisc., 1978.
   Google Scholar
• 54 Fed. Reg. 40618, 40619–40620; 21 C.F.R. 310.530(a), October 2, 1989.
   Google Scholar
• United States v. An Article . . . “Line Away”, 284 F. Supp. 107, D. Del. 1968.
   Google Scholar
• United States v. An Article . . . “Line Away”, 415 F.2d 369, 3rd Cir. 1969.
   Google Scholar
• United States v. An Article . . . Sudden Change, 288 F. Supp. 29, E.D.N.Y. 1968.
   Google Scholar
• United States v. An Article . . . Sudden Change, 409 F.2d. 734, 2d Cir. 1969.
   Google Scholar
• United States v. An Article . . . “Helene Curtis Magic Secret”, 331 F. Supp. 912, D. Md. 1971.
   Google Scholar
• 76 Stat. 780, 1962.
   Google Scholar
• 37 Fed. Reg. 85, Jan. 5, 1972; 37 Fed. Reg. 9464, May 11, 1972; 21 C.F.R. Part 330.
   Google Scholar
• 48 Fed. Reg. 46694, 46701–46702 (vaginal douche products), October 13, 1983.
   Google Scholar
• 54 Fed. Reg. 13490, 13491 (astringent products), April 3, 1989.
   Google Scholar
• 56 Fed. Reg. 63554, 63555 (dandruff products), December 4, 1991.
   Google Scholar
• 37 Fed. Reg. 219, January 7, 1972; 37 Fed. Reg. 20160, September 27, 1972.
   Google Scholar
• 39 Fed. Reg. 33102, September 13, 1974; 40 Fed. Reg. 50527, October 30, 1975.
   Google Scholar
• 40 Fed. Reg. 24328, June 5, 1975; 42 Fed. Reg. 41374, August 16, 1977.
   Google Scholar
• 59 Fed. Reg. 31402, 31440, June 17, 1994. Cf. United States v. Undetermined Quantities . . . “Pets Smellfree” or “Fresh Pet”, 22 F.3d 235, 10th Cir. 1994.
   Google Scholar
• 58 Fed. Reg. 47611, September 9, 1993.
   Google Scholar
• FDA Trade Correspondence No. 61, February 15, 1940.
   Google Scholar
• 58 Fed. Reg. 28194, 28203–28206, May 12, 1993; 64 Fed. Reg. 27666, May 21, 1999.
   Google Scholar
• Egli R.J. The Cosmeceutic-Drug Regulatory Distinction. Drug Discovery Approaches for Developing Cosmeceuticals 1.2.1, W. Hori, 1997
   Google Scholar
• “‘Antiaging’ Creams Challenged,” FDA Talk Paper No. T87-24, May 14, 1987.
   Google Scholar
• Letter from FDA Associate Commissioner for Regulatory Affairs, John M. Taylor, November 19, 1987.
   Google Scholar
• Estee Lauder, Inc. v. FDA, 727 F. Supp. 1, D.D.C. 1989.
   Google Scholar
• FDA issued a strong public warning about “chemical skin peeling products” in FDA Press Release No. P92-13, May 21, 1992.
   Google Scholar
• 15 U.S.C. 1125(a).
   Google Scholar
• Ortho Pharmaceutical Corp. v. Cosprophar, Inc., 828 F. Supp. 1114, S.D.N.Y. 1993.
   Google Scholar
• Ortho Pharmaceutical Corp. v. Cosprophar, Inc., 32 F.3d 690, 2d Cir. 1994.
   Google Scholar
• 62 Fed. Reg. 23350, April 30, 1997.
   Google Scholar
• Fmali Herb, Inc. v. Heckler, 715 Fed. 1385, 9th Cir. 1985.
   Google Scholar
• 61 Fed. Reg. 51625, October 3, 1996; 64 Fed. Reg. 71062, December 20, 1999.
   Google Scholar
• 108 Stat. 4809, 1994.
   Google Scholar
• 21 U.S.C. 383(c), added by 111 Stat. 2296, 2373, 1997.
   Google Scholar
• 60 Fed. Reg. 41314 & 41453, August 11, 1995.
   Google Scholar
• 60 Fed. Reg. at 41467–41470.
   Google Scholar
• 61 Fed. Reg. 44396, August 28, 1996.
   Google Scholar
• 61 Fed. Reg. at 44667.
   Google Scholar
• Coyne Beahm v. FDA, 966 F. Supp. 1374, M.D.N.C. 1997.
   Google Scholar
• Brown & Williamson Tobacco Corp. v. FDA, 153 F.3d 155, 4th Cir. 1998.
   Google Scholar
• 21 C.F.R. 701.3(d).
   Google Scholar
• 21 U.S.C. 352(e)(1)(A)(iii), added by 111 Stat. 2296, 2375, 1997.
   Google Scholar
• 58 Fed. Reg. 28194, May 12, 1993; 64 Fed. Reg. 27666, May 21, 1999.
   Google Scholar
• 62 Fed. Reg. 9024, February 27, 1997; 64 Fed. Reg. 13254, March 17, 1999.
   Google Scholar
• 43 Fed. Reg. 45014, 45027–45028, September 29, 1978.
   Google Scholar
• Letter from FDA Director of the Center for Food Safety and Applied Nutrition, Joseph A. Levitt to CTFA President, E. Edward Kavanaugh, March 30, 1998.
   Google Scholar
• Note 18 supra and accompanying text.
   Google Scholar
• 63 Fed. Reg. 23624, April 29, 1998.
   Google Scholar
• Note 16 supra.
   Google Scholar
• “Potential Health Hazards of Cosmetic Products”, Hearings before the Subcommittee on Regulation and Business Opportunities of the Committee on Small Business, House of Representatives, 100th Cong., 2d Sess. 89, 1988.
   Google Scholar